Tom Loewald, Cambrex CEO
After Chinese CDMO fails, Cambrex acquires ingredient manufacturer Snapdragon Chemistry
While CDMO Cambrex has been expanding steadily throughout the year, its latest acquisition sees a deeper dive into the active pharmaceutical ingredient game.
The New Jersey-based CDMO has agreed to acquire Snapdragon Chemistry, a producer of chemical services and API manufacturing for biopharma customers. The deal will see Cambrex acquire Snapdragon’s two facilities in Waltham, MA. Cambrex did not disclose the deal amount to Endpoints News.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters